Biggest News Aggregation in the World
📰 Continuous Infusion News

Continuous Infusion News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Continuous Infusion. Real-time updates on events, politics, business and more.

No advantage of continuous vs intermittent meropenem in critically ill patients – the MERCY trial

1. The MERCY trial revealed that continuous infusion of meropenem does not confer a significant advantage over intermittent administration in reducing mortality and preventing new antibiotic-resistant bacteria in patients with either septic shock or sepsis. 2. This randomized control trial provides contrary evidence to previous systematic reviews and meta-analyses that found better outcomes with continuous
Intermittent Administration Of Meropenem Rating Level Continuous Infusion Intermittent Administration Critically Ill Patients Simplified Acute Physiology Score

Data Bridge Market Research: Infusion Pump Systems, Accessories and Software Market Set to Reach Highest CAGR of 10.9% by 2029, Size, Share, Demand, Future Growth and Competitors Outlook

BOSTON, Nov. 28, 2022 /PRNewswire/ -- Recent study report released by Data Bridge Market research with titled "Infusion Pump Systems, Accessories and Software Market" (covering USA, Europe,
United States Hong Kong United Kingdom South Korea South Africa Saudi Arabia

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science